Health Care & Life Sciences » Pharmaceuticals | Champions Oncology Inc.

Champions Oncology Inc. | Balance Sheet

Fiscal year is May-April. All values USD Thousands.
2014
2015
2016
2017
2018
Cash & Short Term Investments
5,891.00
9,357.00
2,585.00
3,295.00
856.00
Total Accounts Receivable
1,325.00
1,060.00
1,312.00
2,274.00
3,917.00
Other Current Assets
383.00
346.00
443.00
300.00
287.00
Total Current Assets
7,599.00
10,763.00
4,340.00
5,869.00
5,060.00
Net Property, Plant & Equipment
434.00
452.00
618.00
1,216.00
2,083.00
Total Investments and Advances
165.00
163.00
150.00
150.00
150.00
Intangible Assets
669.00
669.00
669.00
669.00
669.00
Other Assets
-
-
-
107.00
116.00
Total Assets
8,867.00
12,047.00
5,777.00
8,011.00
8,078.00
ST Debt & Current Portion LT Debt
-
-
24.00
25.00
26.00
Accounts Payable
981.00
1,414.00
1,896.00
1,852.00
2,154.00
Other Current Liabilities
2,678.00
2,382.00
3,386.00
5,570.00
5,273.00
Total Current Liabilities
3,659.00
3,796.00
5,306.00
7,447.00
7,453.00
Long-Term Debt
-
-
59.00
38.00
16.00
Provision for Risks & Charges
-
100.00
165.00
-
-
Other Liabilities
2,011.00
92.00
9.00
126.00
606.00
Total Liabilities
5,670.00
3,988.00
5,539.00
7,611.00
8,075.00
Common Equity (Total)
3,197.00
8,059.00
238.00
400.00
3.00
Total Shareholders' Equity
3,197.00
8,059.00
238.00
400.00
3.00
Total Equity
3,197.00
8,059.00
238.00
400.00
3.00
Liabilities & Shareholders' Equity
8,867.00
12,047.00
5,777.00
8,011.00
8,078.00

About Champions Oncology

View Profile
Address
One University Plaza
Hackensack New Jersey 07601
United States
Employees -
Website http://www.championsoncology.com
Updated 07/08/2019
Champions Oncology, Inc. engages in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. Its technology platform, TumorGraft, is a novel approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. It uses its technology to offer solutions to Translational Oncology Solutions, which includes pharmaceutical and biotechnology companies; and Personalized Oncology, which assists physicians in developing personalized treatment options for their cancer patients.